LP16198-1MethotrexateActive
Descriptions
LP16198-1 Methotrexate
High-dose methotrexate (MTX) is an antimetabolite drug used in treatment of cancer, and low-dose methotrexate (MTX) is used as a disease modifying antirheumatic drug (DMARD) for long-term treatment of rheumatoid arthritis (RA), psoriasis, and other autoimmune diseases. Methotrexate is a first-line drug in RA treatment. One challenge in the use of the drug is that about 30% of patients do not respond to treatment or experience adverse effects, such as gastrointestinal symptoms, malaise, and psychological complaints. [PMID:20665136]
Source: Regenstrief LOINC, PMID: 20665136
LP16198-1 Methotrexate
An anti-neoplastic anti-metabolite with immunosuppressant properties. It inhibits tetrahydrofolate dehydrogenase and prevents the formation of tetrahydrofolate, an essential component of DNA, necessary for synthesis of thymidylate.
Source: National Library of Medicine, MeSH 2006
Basic Part Properties
- Name
- Methotrexate
- Type
- Component
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- MTX
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP16198-1
Language Variants Get Info
- zh-CNChinese (China)
- 氨甲喋呤
Synonyms: C20H22N8O5;甲氨喋呤; 氨甲基叶酸; 氨甲蝶呤; 甲基蝶啶胺; 甲基蝶啶胺(化学不孕剂) - nl-NLDutch (Netherlands)
- methotrexaat
- et-EEEstonian (Estonia)
- Metotreksaat
- fr-BEFrench (Belgium)
- Méthotrexate
- fr-CAFrench (Canada)
- Méthotrexate
- it-ITItalian (Italy)
- Metotrexato
- ru-RURussian (Russian Federation)
- Метотрексат
- es-ESSpanish (Spain)
- Metotrexato
Synonyms: MTX ® - tr-TRTurkish (Turkey)
- Metotreksat
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright